INTREPID (A randomized, double-blind, sham-controlled study of subthalamic nucleus (STN) deep brain stimulation (DBS) for the treatment of individuals with Parkinson disease; NCT01839396)
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Imaging & Testing
Neuroimaging: Clinical Impact of Imaging Findings
Laszlo Mechtler, MD, FAAN, FEAN, FASN, FAHSLaszlo Mechtler, MD, FAAN, FEAN, FASN, FAHS - Imaging & Testing
Practical MRI in Neurology: Use Cases, Technologies, and Opportunities for Outpatient Clinics
Joseph Fritz, PhD; Edmond A. Knopp, MD, DABR, FASFNRJoseph Fritz, PhD; Edmond A. Knopp, MD, DABR, FASFNR - Movement Disorders
Understanding Dystonia: A Practical Approach to Diagnosis and Management
Tiziana De Santis, MD; Steven J. Frucht, MDTiziana De Santis, MD; Steven J. Frucht, MD - Movement Disorders
Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
Jorge Patino, MDJorge Patino, MD
